WILMINGTON, N.C., Aug. 7 /PRNewswire-FirstCall/ -- PPD, Inc. today announced Susan Atkinson, Ph.D., has been promoted to senior vice president of global biostatistics and data management. In her new role, Dr. Atkinson provides strategic direction for the company’s global biostatistics and data management business, including electronic data capture operations, CSS Informatics and PPD Medical Device.
“Throughout her tenure with PPD, Dr. Atkinson has demonstrated the ability to build effective teams and deliver the highest level of quality service to our customers,” said William Sharbaugh, chief operating officer of PPD. “Her expertise in statistical analysis, clinical trial design, regulatory submission strategies and EDC will serve her well in leading her group in providing clients integrated services for the conduct of multinational clinical trials.”
Dr. Atkinson joined PPD in 1991 as a senior biostatistician and has held a series of leadership positions with increasing responsibility. Most recently, she oversaw Phase I-IV biostatistics, programming and data management for PPD’s U.S. operations. In addition, she guided the health outcomes group, interactive voice response group, EDC operations and PPD Medical Device.
Prior to joining PPD, Dr, Atkinson held a variety of consulting assignments with leading pharmaceutical companies and other clinical research organizations. She began her career as a research statistician in the biometric consulting laboratory of the department of biostatistics at the University of North Carolina at Chapel Hill.
Dr. Atkinson holds a doctorate and master’s degree in biostatistics and a bachelor’s degree in public health (biostatistics) from the University of North Carolina at Chapel Hill.
PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 28 countries and more than 9,700 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at http://www.ppdi.com.
Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the contributions of Dr. Atkinson to our global biostatistics and data management group, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: the ability to attract and retain key personnel; rapid technological advances that make our products and services less competitive; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; success in sales growth; loss of large contracts; increased cancellation rates; competition within the outsourcing industry; risks associated with and dependence on collaborative relationships; risks associated with the development and commercialization of drugs; risks associated with acquisitions and investments, such as impairments; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.
Contacts Media: Louise Caudle +919 456 4467 louise.caudle@rtp.ppdi.com Analysts/Investors: Steve Smith +910 558 7585 stephen.smith@wilm.ppdi.com
PPD, Inc.
CONTACT: Media, Louise Caudle, +1-919-456-4467,louise.caudle@rtp.ppdi.com, or Analysts-Investors, Steve Smith,+1-910-558-7585, stephen.smith@wilm.ppdi.com, both of PPD, Inc.
Web site: http://www.ppdi.com//
